Ani Pharmaceuticals Inc - ANIP

Latest data: 12/20/2024 10:22:22 PM
EDGAR CIK 0001023024

Buy Breakdown

Total $0

Sell Breakdown

Total $8,811,378

Monthly Totals

Transaction Filed Name Type Shares @ Price Value Balance change Ownership
12/17/2024
12/18/2024
SVP & CFO
CFO
Sell
-7,500 @ $55.79
($418,425.00)
154,468 (-4.63%) Direct
12/13/2024
10b5-1
12/16/2024
SR. VP, GENERAL COUNSEL & SEC.
Officer
Sell
-250 @ $56.24
($14,060.00)
55,988 (-0.44%) Direct
12/11/2024
10b5-1
12/12/2024
SVP, CHIEF HR OFFICER
Officer
Sell
-1,000 @ $60.00
($60,000.00)
49,059 (-2.00%) Direct
11/15/2024
11/18/2024
HEAD OF RARE DISEASE
Officer
Sell
-6,500 @ $57.70
($375,050.00)
76,777 (-7.81%) Direct
11/13/2024
10b5-1
11/14/2024
SR. VP, GENERAL COUNSEL & SEC.
Officer
Sell
-250 @ $61.36
($15,340.00)
56,238 (-0.44%) Direct
10/14/2024
10b5-1
10/15/2024
SR. VP, GENERAL COUNSEL & SEC.
Officer
Sell
-250 @ $57.19
($14,297.50)
56,488 (-0.44%) Direct
09/13/2024
10b5-1
09/16/2024
SR. VP, GENERAL COUNSEL & SEC.
Officer
Sell
-250 @ $56.82
($14,205.00)
56,738 (-0.44%) Direct
08/13/2024
10b5-1
08/14/2024
SR. VP, GENERAL COUNSEL & SEC.
Officer
Sell
-250 @ $59.62
($14,905.00)
56,988 (-0.44%) Direct
07/12/2024
10b5-1
07/15/2024
SR. VP, GENERAL COUNSEL & SEC.
Officer
Sell
-250 @ $64.91
($16,227.50)
58,981 (-0.42%) Direct
06/13/2024
10b5-1
06/14/2024
SR. VP, GENERAL COUNSEL & SEC.
Officer
Sell
-250 @ $63.80
($15,950.00)
59,231 (-0.42%) Direct
06/05/2024
06/06/2024
SVP, GENERICS
Officer
Sell
-2,985 @ $67.00
($199,995.00)
77,227 (-3.72%) Direct
06/04/2024
06/06/2024
SVP & CFO
CFO
Sell
-5,000 @ $63.58
($317,900.00)
161,968 (-2.99%) Direct
05/21/2024
05/22/2024
HEAD OF RARE DISEASE
Officer
Sell
-2,000 @ $61.61
($123,220.00)
83,277 (-2.35%) Direct
05/16/2024
05/17/2024
Director
Sell
-2,000 @ $63.87
($127,740.00)
18,211 (-9.90%) Direct
05/14/2024
05/16/2024
PRESIDENT & CEO
CEO Director
Sell
-16,669 @ $66.10
($1,101,820.90)
377,505 (-4.23%) Direct
05/13/2024
10b5-1
05/13/2024
SR. VP, GENERAL COUNSEL & SEC.
Officer
Sell
-250 @ $67.69
($16,922.50)
59,481 (-0.42%) Direct
04/12/2024
10b5-1
04/15/2024
SR. VP, GENERAL COUNSEL & SEC.
Officer
Sell
-250 @ $67.79
($16,947.50)
59,731 (-0.42%) Direct
03/13/2024
10b5-1
03/13/2024
SR. VP, GENERAL COUNSEL & SEC.
Officer
Sell
-250 @ $66.54
($16,635.00)
59,981 (-0.42%) Direct
03/11/2024
03/11/2024
SVP & CFO
CFO
Sell
-7,787 @ $65.55
($510,437.85)
177,712 (-4.20%) Direct
03/08/2024
03/08/2024
PRESIDENT & CEO
CEO Director
Sell
-16,292 @ $67.13
($1,093,681.96)
411,629 (-3.81%) Direct
03/07/2024
03/07/2024
SVP OPS & PROD DEV
Officer
Sell
-24,338 @ $66.37
($1,615,313.06)
124,492 (-16.35%) Direct
03/06/2024
03/08/2024
PRESIDENT & CEO
CEO Director
Sell
-28,965 @ $65.52
($1,897,786.80)
444,981 (-6.11%) Direct
03/05/2024
03/06/2024
HEAD OF RARE DISEASE
Officer
Sell
-5,000 @ $66.00
($330,000.00)
87,387 (-5.41%) Direct
03/04/2024
03/06/2024
Director
Sell
-7,000 @ $65.20
($456,400.00)
26,627 (-20.82%) Direct
02/13/2024
10b5-1
02/13/2024
SR. VP, GENERAL COUNSEL & SEC.
Officer
Sell
-250 @ $56.04
($14,010.00)
36,799 (-0.67%) Direct
01/12/2024
10b5-1
01/16/2024
SR. VP, GENERAL COUNSEL & SEC.
Officer
Sell
-250 @ $56.43
($14,107.50)
37,049 (-0.67%) Direct